Search
Cartesian Therapeutics Inc
RNACAdd to Watchlist
6.280USD
+0.100+1.62%
Close 10-26 16:00（ET）
190.03MMarket Cap
LossP/E TTM
Today
+1.62%
5 Days
+3.29%
1 Month
-15.25%
6 Months
-6.96%
Year to Date
-12.90%
1 Year
-31.44%
Key Figures
6.250Open
6.320High
3.18KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.01%Turnover Ratio
6.180Prev. Close
6.070Low
19.75KTurnover
LossP/E Static
-1.51P/B
0.00%Div Yield TTM
-43.52%ROA
11.00052wk High
0.02Volume Ratio
-77.42MNet Profit
30.26MShares
-5.7921EPS TTM
0.48Beta
-924.61%ROE
5.60052wk Low
6.63%Amplitude
100.00%Gross Margin
190.03MMarket Cap
1.49Reward/Risk
5.23%Risk Rate
Cartesian Therapeutics Inc's Score
-0.16vs previous score
Forecast8.86
Financial Health5.43
Technical4.58
Valuation Dimensions8.26
Institutional Confidence3.00
Risk Assessment2.39
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Cartesian Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
0.47/-0.87
Revenue / Forecast
0.00/134.75K
Cartesian Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolRNAC
Number of employees66
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Springer Timothy A | 29.41% |
| Seven One Eight Three Four Irrevocable Trust | 15.50% |
| Squarepoint Capital LLP | 7.52% |
| Fidelity Management & Research Company LLC | 4.65% |
| Shareholder Types | Proportion |
|---|---|
| Individual Investor | 36.03% |
| Corporation | 17.74% |
| Investment Advisor | 11.14% |
| Investment Advisor/Hedge Fund | 10.75% |
Related Instruments
+0.45%
+0.94%
+0.39%
-3.21%
+1.78%
+0.33%
+1.22%
+1.70%
+0.20%
-0.80%
-1.23%
+0.21%
-0.79%
+0.69%
+0.46%
+0.33%
-0.62%
+0.94%
+0.79%
-0.50%
FAQs
What is the current price of Cartesian Therapeutics Inc (RNAC)?
The current price of Cartesian Therapeutics Inc (RNAC) is 6.28.
What is the symbol of Cartesian Therapeutics Inc?
The ticker symbol of Cartesian Therapeutics Inc is RNAC.
What is the 52-week high of Cartesian Therapeutics Inc?
The 52-week high of Cartesian Therapeutics Inc is 11.00.
What is the 52-week low of Cartesian Therapeutics Inc?
The 52-week low of Cartesian Therapeutics Inc is 5.60.
What is the market capitalization of Cartesian Therapeutics Inc?
The market capitalization of Cartesian Therapeutics Inc is 190.03M.
Is Cartesian Therapeutics Inc (RNAC) currently rated as Buy, Hold, or Sell?
According to analysts, Cartesian Therapeutics Inc (RNAC) has an overall rating of Buy, with a price target of 33.67.
What is the Earnings Per Share (EPS TTM) of Cartesian Therapeutics Inc (RNAC)?
The Earnings Per Share (EPS TTM) of Cartesian Therapeutics Inc (RNAC) is -5.79.